Intellectual property assets are essential to the competitive survival of life sciences companies and are typically one of the significant value drivers for such business transactions as mergers and acquisitions, joint collaborations and license transactions. However, the unique nature of intellectual property rights can create inadvertent legal traps that can jeopardize the value of the transaction by not allowing the parties to realize the full benefit of the intellectual property they were hoping to acquire or exploit.
In this 60-minute presentation, partners Deborah Schavey Ruff and Vera Nackovic and associate Melissa Anyetei will discuss what life sciences companies need to watch out for and will offer practical steps to avoid these traps. Through a series of examples, they will reveal some of the most common traps in intellectual property licensing encountered by life sciences companies today. Topics to be addressed include:
- Licensing of jointly owned intellectual property
- Issues in sublicensing
- Managing intervening rights
- Current versus future assignments
- Licensing of after-acquired intellectual property
Learn more about our Intellectual Property practice.
CLE is not available for individual viewing/self-study.